hepatitis d, chronic
Showing 1 - 11 of 11
Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)
Active, not recruiting
- Hepatitis D, Chronic
- JNJ-73763989
- +4 more
-
Redwood City, California
- +68 more
Jan 17, 2023
Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)
Completed
- Hepatitis D, Chronic
- Peginterferon Lambda-1A
-
Beersheba, Israel
- +3 more
Dec 20, 2022
Bulevirtide in Patients With Chronic HBV/HDV Co-infection
Recruiting
- Hepatitis D, Chronic
- Hepatitis B, Chronic
-
Lyon, FranceZOULIM
Aug 5, 2021
Study of Patients From the REP 301 Protocol
Completed
- Hepatitis B, Chronic
- Hepatitis D, Chronic
-
Chisinau, Moldova, Republic ofInfectious Clinical Hospital (n.a. Toma Ciorba)
Oct 5, 2020
Hepatitis D, Chronic Trial in Turkey (peginterferon alfa-2a [Pegasys], , tenofovir)
Completed
- Hepatitis D, Chronic
- peginterferon alfa-2a [Pegasys]
- +2 more
-
Ankara, Turkey
- +5 more
Jan 11, 2019
Hepatitis D, Chronic Trial (Pegylated interferon alfa, Ezetimibe)
Unknown status
- Hepatitis D, Chronic
- Pegylated interferon alfa
- Ezetimibe
- (no location specified)
Apr 3, 2017
Chronic Hepatitis D in Romania and Efficacy of Treatment With
Terminated
- Hepatitis D, Chronic
-
Bucharest, Romania(unnamed)
Nov 1, 2016
Hepatitis D, Chronic Trial in Romania (Pegylated Interferon (PEG-IFN) alfa-2a)
Completed
- Hepatitis D, Chronic
- Pegylated Interferon (PEG-IFN) alfa-2a
-
Bucharest, Romania
- +6 more
Jul 15, 2016
Hepatitis D, Chronic Trial in Cagliari (Peginterferon alfa-2a, Ribavirin)
Completed
- Hepatitis D, Chronic
- Peginterferon alfa-2a
- Ribavirin
-
Cagliari, Italy(unnamed)
Jun 3, 2016